Tech Company Financing Transactions
Aptus Endosystems Funding Round
On 3/28/2006, Aptus Endosystems secured $19.5 million in Series B funding from Prism VentureWorks, Baird Capital and FirstMark Capital.
Transaction Overview
Company Name
Announced On
3/28/2006
Transaction Type
Venture Equity
Amount
$19,500,000
Round
Series B
Investors
Proceeds Purpose
Aptus President Bob Katz says the company plans to use the financing to launch a clinical trial in the U.S. in the next two quarters.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
271 Gibraltar Dr.
Sunnyvale, CA 94085
USA
Sunnyvale, CA 94085
USA
Phone
Website
Email Address
Overview
Aptus Endosystems is a privately held, well-funded, emerging medical device company that is engaged in the development of next generation minimally invasive endograft devices, delivery systems and fixation technology for the treatment of Abdominal Aortic Aneurysm - the 13th leading cause of death in the United States and the 10th leading cause of death in men over the age of 55.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Reinstein
Chief Operating Officer
Jeff Elkins
Chief Technical Officer
Lee Bolduc
VP - Finance
Dian Georgia
VP - Marketing
Deepak Srikant
VP - Regulatory Affairs
Burt Goodson
Browse more venture capital transactions:
Prev: 3/27/2006: Zopa venture capital transaction
Next: 3/28/2006: AmberPoint venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record all VC transactions involving tech companies. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs